GGrantIndex
Sort

78,016 grants matching breast cancer

Technology to Select Candidates for Prophylactic Treatments to Prevent Sporadic Breast Cancers

$1,009,044
Indira None Poola · Silbiotech, Inc. · R44 · FY2016 · CA

An integrated computational and functional genomics discovery engine for preclini

$1,009,007
Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA

Identification of epithelial tumor susceptibility genes

$1,008,772
Allan Balmain · University Of California, San Francisco · U01 · FY2007 · CA

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$1,008,742
Olorunseun O Ogunwobi · Hunter College · U54 · FY2021 · CA

CCOP: Colorado Cancer Research Program

$1,008,553
Eduardo R Pajon · Western States Cancer Research Ncorp · U10 · FY2011 · CA

Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development

$1,008,464
Joan Siefert Brugge · Harvard Medical School · R35 · FY2025 · CA

HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES

$1,008,214
University Of California Irvine · U01 · FY2001 · CA

Robust Predictor of Breast Cancer Risk

$1,008,203
Harry Ostrer · Morgan And Mendel Genomics, Inc. · R42 · FY2021 · CA

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$1,008,081
Olorunseun O Ogunwobi · Hunter College · U54 · FY2019 · CA

CENTER FOR DEVELOPMENTAL AND MOLECULAR TOXICOLOGY

$1,008,000
University Of Wisconsin Madison · P30 · FY2001 · ES

Targeting intratumor heterogeneity in breast cancer

$1,007,771
Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2024 · CA

Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

$1,007,656
Venkataramanan Krishnaswamy · Cairnsurgical, Inc. · R44 · FY2020 · CA

Telomere maintenance and replication fork progression in yeast and human cells

$1,007,612
Virginia A. Zakian · Princeton University · R35 · FY2020 · GM

Late Effects of Treatment in Wilms Tumor Survivors and Offspring

$1,007,340
Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

$1,007,233
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2021 · CA

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

$1,007,233
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2018 · CA

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

$1,007,233
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2017 · CA

Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer

$1,007,233
Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2020 · CA

Young Women With Acute Myocardial Infarction

$1,007,096
Harlan M Krumholz · Yale University · R01 · FY2012 · HL

Synthetic Approaches to Carcinogen-Linked Oligonucleotides

$1,006,869
Carmelo J Rizzo · Vanderbilt University · P01 · FY2013 · CA

A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor Margins

$1,006,706
Nimmi Ramanujam · Duke University · R01 · FY2013 · EB

Genetic Epidemiology of Lung Cancer

$1,006,509
Marshall W Anderson · University Of Cincinnati · U01 · FY2008 · CA

PRE-CLINICAL COMBINATION CHEMO- AND RADIOANTIBODY THERAP

$1,006,461
Ctr For Molecular Medicine/Immunology · R01 · FY2005 · CA

Automated Systems for Detection and Molecular Characterization of Circulating Tum

$1,006,336
Yuling Luo · Advanced Cell Diagnostics, Inc. · R44 · FY2011 · CA

A RESOURCE FOR BIOMEDICAL MASS SPECTROMETRY

$1,005,225
Washington University · P41 · FY2002 · RR